Press Enter to search · Esc to close
A new mediation analysis points to E-selectin, a marker of blood-vessel stress, as a quiet link between metabolic risk and insulin resistance — while CRP, the inflammation test most of us know, came up short.
A new 2,798-person disparities cohort puts the leading Alzheimer's blood test under a fairness lens. The biomarker held up across groups — the single threshold did not.
A new study trained a machine-learning model on routine blood, urine and saliva tests from 11,554 people — and the labs already in your annual physical may carry more aging signal than the boutique clocks selling it back to you.
A small serum study fingers two circulating lipids — nervonic acid and 15-epi-PGA1 — that throttle mitochondria in a dish. It's early, but it reframes Alzheimer's as a whole-body energy problem.
Two new datasets reframe metabolic risk from inevitability to variability — hunting the protective phenotypes that shrug off vascular damage, and the routine labs that flag your five-year diabetes window.
Chinese researchers built an early-stage 'aging clock' from amino acids, vitamins and oxidative-stress markers — a promising step toward biological age you might actually be able to nudge.
A new study links handgrip, finger pinch, and even tongue strength to a blood marker tied to Alzheimer's pathology — hinting that simple bedside checks could one day flag risk early.
A 1,416-patient analysis suggests a curated senescence gene signature tracks with survival in multiple myeloma — an early but credible sign that geroscience biomarkers may sharpen oncology prognosis.
A new analysis of plasma biomarkers suggests a simple blood draw may flag who is heading toward Alzheimer's while there is still time to act. The evidence is promising, not definitive.
A large multiomic study links later menopause with healthier prefrontal cortex aging decades on — a finding worth knowing for the women in your life, and for what it suggests about how the body ages as one system.